NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) to Johnson & Johnson for $52.50 per share in cash is fair to Momenta shareholders. On behalf of Momenta shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
If you are a Momenta shareholder and would like to discuss your legal rights and options, please visit Momenta Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
The investigation concerns whether Momenta and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to (1) obtain the best possible consideration for Momenta shareholders; (2) determine whether Johnson & Johnson is underpaying for Momenta; and (3) disclose all material information necessary for Momenta shareholders to adequately assess and value the proposed transaction.
If you are a Momenta shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/momenta-pharmaceuticals-inc-stock-merger-jnj or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
SOURCE: Halper Sadeh LLP